JW
Jitendra Wadhane
Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial OfficerMr. Jitendra Wadhane, also known as Jitu, C.A, C.P.A., is Principal Financial Officer of Pyxis Oncology, Inc. from July 1, 2025 and has been Chief Accounting Officer since August 3, 2022 and has been its Senior Vice President of Finance and Corporate Controller since August 2021. From April 2020 to August 2021, Mr. Wadhane was Head of SEC Reporting and Technical Accounting at Immunovant, Inc., a biopharmaceutical company and from February 2012 to April 2020, he was a Senior Manager with Ernst & Young LLP, an accounting firm. Mr. Wadhane is a Certified Public Accountant and received his Bachelors Degree from the University of Mumbai and Chartered Accountancy from the Institute of Chartered Accountants of India.
Positions
- Company NamePyxis Oncology, Inc.Stock CodePYXSPositionChief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial OfficerColleagues
- TCThomas CivikCEO & Chairman
- BNBalu N. BalasubramanianInterim Chief Technology Officer
- DRDonna RegaladoHead of Human Resources
- CTCharles T. GombarSenior Vice President of Portfolio & Program Management
- JLJohn L. FlavinLead Independent Director
- DSDarren S. ClineIndependent Director
- MRMorris RosenbergChairperson of Technical Advisory Board
- COChristopher O’DonnellMember of Technical Advisory Board
